Robertson, J. F., Bondarenko, I. M., Trishkina, E., Dvorkin, M., Panasci, L., Manikhas, A., . . . Ellis, M. J. (2017). Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): An international, randomised, double-blind, phase 3 trial. Elsevier.
Chicago Style (17th ed.) CitationRobertson, John F.R., et al. Fulvestrant 500 Mg Versus Anastrozole 1 Mg for Hormone Receptor-positive Advanced Breast Cancer (FALCON): An International, Randomised, Double-blind, Phase 3 Trial. Elsevier, 2017.
MLA (9th ed.) CitationRobertson, John F.R., et al. Fulvestrant 500 Mg Versus Anastrozole 1 Mg for Hormone Receptor-positive Advanced Breast Cancer (FALCON): An International, Randomised, Double-blind, Phase 3 Trial. Elsevier, 2017.
Warning: These citations may not always be 100% accurate.